Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 4Breast 4Thoracic 3Other solid neoplasm 3Myeloid 2Head & Neck 2Gastrointestinal 2Dermatologic 2Sarcoma 1Plasma cell 1Gynecologic 1Genitourinary 1Endocrine 1Classical hematology 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Solitary Fibrous Tumor, Pleural 1Mesothelioma, Malignant 1

Interventions

pembrolizumab 26Pemetrexed 26Cisplatin 25Nivolumab 22Carboplatin 16Paclitaxel 14Gemcitabine 12Ipilimumab 11tislelizumab 8durvalumab 8Ramucirumab 8Docetaxel 8talazoparib 7Fluorouracil 7Radiotherapy 6Capecitabine 6tremelimumab 5cobimetinib 5atezolizumab 5adavosertib 5Radiosurgery 5Cyclophosphamide 5Bevacizumab 5olaparib 4avelumab 4Temozolomide 4Sunitinib 4Specimen Handling 4Platinum 4PM 01183 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Pharmacogenomic Testing × Other solid neoplasm × Clear all
NCT02399371 2026-05-08

Pembrolizumab in Treating Patients With Malignant Mesothelioma

University of Chicago

Phase 2 Completed
65 enrolled 12 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT01206465 2023-12-26

Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors

University of Nebraska

Phase 1 Completed
29 enrolled 12 charts
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01705106 2018-05-30

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

University of Chicago

Phase 1 Terminated
21 enrolled 5 charts
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡